Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia - PubMed (original) (raw)

doi: 10.1016/j.ccr.2005.10.004.

Matthew E R Butchbach, Zarife Sahenk, Huating Wang, Motoyasu Saji, Micheal Carathers, Matthew D Ringel, Richard J E Skipworth, Kenneth C H Fearon, Michael A Hollingsworth, Peter Muscarella, Arthur H M Burghes, Jill A Rafael-Fortney, Denis C Guttridge

Affiliations

Free article

Swarnali Acharyya et al. Cancer Cell. 2005 Nov.

Free article

Abstract

Cachexia contributes to nearly a third of all cancer deaths, yet the mechanisms underlying skeletal muscle wasting in this syndrome remain poorly defined. We report that tumor-induced alterations in the muscular dystrophy-associated dystrophin glycoprotein complex (DGC) represent a key early event in cachexia. Muscles from tumor-bearing mice exhibited membrane abnormalities accompanied by reduced levels of dystrophin and increased glycosylation on DGC proteins. Wasting was accentuated in tumor mdx mice lacking a DGC but spared in dystrophin transgenic mice that blocked induction of muscle E3 ubiquitin ligases. Furthermore, DGC deregulation correlated positively with cachexia in patients with gastrointestinal cancers. Based on these results, we propose that, similar to muscular dystrophy, DGC dysfunction plays a critical role in cancer-induced wasting.

PubMed Disclaimer

Comment in

Publication types

MeSH terms

Substances

LinkOut - more resources